Role of immunoproteasomes in cross-presentation

Journal of Immunology

Volumn 177, Issue 2, 2006, Pages 983-990

  Palmowski, Michael J ^a   Gileadi, Uzi ^a   Salio, Mariolina ^a   Gallimore, Awen ^a   Millrain, Maggie ^b   James, Edward ^b   Addey, Caroline ^b   Scott, Diane ^b   Dyson, Julian ^b   Simpson, Elizabeth ^b   Cerundolo, Vincenzo ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; IMMUNOPROTEASOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS PRESENTATION; FEMALE; GRAFT REJECTION; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN TRANSPLANTATION; T LYMPHOCYTE ACTIVATION;

EID: 33745830160     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.2.983     Document Type: Article

References (50)

1. Ackerman, A. L., and P. Cresswell. 2004. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5: 678-684.
2. Guermonprez, P., and S. Amigorena. 2005. Pathways for antigen cross presentation. Semin. Immun. 26: 257-271.
3. Huang, A. Y., A. T. Bruce, D. M. Pardoll, and H. I. Levitsky. 1996. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 4: 349-355.
4. Kovacsovics-Bankowski, M., and K. L. Rock. 1995. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267: 243-246.
5. Guermonprez, P., L. Saveanu, M. Kleijmeer, J. Davoust, P. Van Endert, and S. Amigorena. 2003. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 425: 397-402.
6. Houde, M., S. Bertholet, E. Gagnon, S. Brunet, G. Goyette, A. Laplante, M. F. Princiotta, P. Thibault, D. Sacks, and M. Desjardins. 2003. Phagosomes are competent organelles for antigen cross-presentation. Nature 425: 402-406.
7. Groothuis, T. A. M., and J. Neefjes. 2005. The many roads to cross-presentation. J. Exp. Med. 10: 1313-1318.
8. Touret, N., P. Paroutis, M. Terebiznik, R. E. Harrison, S. Trombetta, M. Pypaert, A. Chow, A. Jiang, J. Shaw, C. Yip, et al. 2005. Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell 123: 157-170.
9. Van Kaer, L., P. G. Ashton-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K. L. Rock, A. L. Goldberg, P. C. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1: 533-541.
10. Cerundolo, V., A. Kelly, T. Elliott, J. Trowsdale, and A. Townsend. 1995. Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur. J. Immunol. 25: 554-562.
11. Cerundolo, V., A. Benham, V. Braud, S. Mukherjee, K. Gould, B. Macino, J. Neefjes, and A. Townsend. 1997. The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur. J. Immunol. 27: 336-341.
12. Gileadi, U., H. T. Moins-Teisserenc, I. Correa, B. L. Booth, Jr., P. R. Dunbar, A. K. Sewell, J. Trowsdale, R. E. Phillips, and V. Cerundolo. 1999. Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein. J. Immunol. 163: 6045-6052.
13. Toes, R. E., A. K. Nussbaum, S. Degermann, M. Schirle, N. P. Emmerich, M. Kraft, C. Laplace, A. Zwinderman, T. P. Dick, J. Muller, et al. 2001. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 194: 1-12.
14. + T cells at the levels of T cell repertoire and presentation of viral antigens. J. Exp. Med. 193: 1319-1326.
15. Groettrup, M., M. van den Broek, K. Schwarz, A. Macagno, S. Khan, R. de Giuli, and G. Schmidtke. 2001. Structural plasticity of the proteasome and its function in antigen processing. Crit. Rev. Immunol. 21: 339-358.
16. Wolkers, M. C., N. Brouwenstijn, A. H. Bakker, M. Toebes, and T. N. Schumacher. 2004. Antigen bias in T cell cross-priming. Science 304: 1314-137.
17. + T cell cross-priming via transfer of proteasome substrates. Science 304: 1318-1321.
18. Norbury, C. C., L. J. Hewlett, A. R. Prescott, N. Shastri, and C. Watts. 1995. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 3: 783-791.
19. Norbury, C. C., B. J. Chambers, A. R. Prescott, H. G. Ljunggren, and C. Watts. 1997. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27: 280-288.
20. Shen, L., L. J. Sigal, M. Boes, and K. L. Rock. 2004. Important role of cathepsin S in generating peptides for TAP-independent MHC class I cross-presentation in vivo. Immunity 21: 155-165.
21. Ortiz-Navarrete, V., A. Seelig, M. Gernold, S. Frentzel, P. M. Kloetzel, and G. J. Hammerling. 1991. Subunit of the "20S" proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex. Nature 353: 662-664.
22. Martinez, C. K., and J. J. Monaco. 1991. Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene. Nature 353: 664-667.
23. Kelly, A., S. H. Powis, R. Glynne, E. Radley, S. Beck, and J. Trowsdale. 1991. Second proteasome-related gene in the human MHC class II region. Nature 353: 667-668.
24. Aki, M., N. Shimbara, M. Takashina, K. Akiyama, S. Kagawa, T. Tamura, N. Tanahashi, T. Yoshimura, K. Tanaka, and A. Ichihara. 1994. Interferon-γ induces different subunit organizations and functional diversity of proteasomes. J. Biochem. 115: 257-269.
25. b epitope is encoded by a novel mouse Y chromosome gene. Nat. Genet. 14: 474-478.
26. Scott, D. M., I. E. Ehrmann, P. S. Ellis, C. E. Bishop, A. I. Agulnik, E. Simpson, and M. J. Mitchell. 1995. Identification of a mouse male-specific transplantation antigen, H-Y. Nature 376: 695-698.
27. Markiewicz, M. A., C. Girao, J. T. Opferman, J. Sun, Q. Hu, A. A. Agulnik, C. E. Bishop, C. B. Thompson, and P. G. Ashton-Rickardt. 1998. Long-term T cell memory requires the surface expression of self-peptide/major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 95: 3065-3070.
28. Hermans, I. F., J. D. Silk, J. Yang, M. J. Palmowski, U. Gileadi, C. McCarthy, M. Salio, F. Ronchese, and V. Cerundolo. 2004. The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J. Immunol. Methods 285: 25-40.
29. Fehling, H. J., W. Swat, C. Laplace, R. Kuhn, K. Rajewsky, U. Muller, and H. von Boehmer. 1994. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265: 1234-127.
30. Palmowski, M. J., E. M. Choi, I. F. Hermans, S. C. Gilbert, J. L. Chen, U. Gileadi, M. Salio, A. Van Pel, S. Man, E. Bonin, et al. 2002. Competition between CTL narrows the immune response induced by prime-boost vaccination protocols. J. Immunol. 168: 4391-438.
31. Palmowski, M. J., L. Lopes, Y. Ikeda, M. Salio, V. Cerundolo, and M. K. Collins. 2004. Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response. J. Immunol. 172: 1582-157.
32. Hosaka, Y., Y. Yasuda, O. Seriburi, M. G. Moran, and K. Fukai. 1986. In vitro secondary generation of cytotoxic T lymphocytes in mice with mumps virus and their mumps-specific cytotoxicity among paramyxoviruses. J. Virol. 57: 1113-118.
33. + T cell determinants to enable rational design and characterization of smallpox vaccines. J. Exp. Med. 201: 95-104.
34. King, T. R., G. J. Christianson, M. J. Mitchell, C. E. Bishop, D. Scott, I. Ehrmann, E. Simpson, E. M. Eicher, and D. C. Roopenian. 1994. Deletion mapping by immunoselection against the H-Y histocompatibility antigen further resolves the Sxra region of the mouse Y chromosome and reveals complexity of the Hya locus. Genomics 24: 159-168.
35. Millrain, M., P. Chandler, F. Dazzi, D. Scott, E. Simpson, and P. J. Dyson. 2001. Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis. J. Immunol. 167: 3756-3764.
36. Meng, L., R. Mohan, B. H. Kwok, M. Elofsson, N. Sin, and C. M. Crews. 1999. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity. Proc. Natl. Acad. Sci. USA 96: 10403-10408.
37. Billingham R, M. P. 1951. The technique of free skin grafting in mammals. J. Exp. Biol. 28: 385-402.
38. Gileadi, U., A. Gallimore, P. Van der Bruggen, and V. Cerundolo. 1999. Effect of epitope flanking residues on the presentation of N-terminal cytotoxic T lymphocyte epitopes. Eur. J. Immunol. 29: 2213-2222.
39. Khan, S., M. van den Broek, K. Schwarz, R. de Giuli, P. A. Diener, and M. Groettrup. 2001. Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver. J. Immunol. 167: 6859-6868.
40. Scott, D., C. Addey, P. Ellis, E. James, M. J. Mitchell, N. Saut, S. Jurcevic, and E. Simpson. 2000. Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens. Immunity 12: 711-720.
41. Geier, E., G. Pfeifer, M. Wilm, M. Lucchiari-Hartz, W. Baumeister, K. Eichmann, and G. Niedermann. 1999. A giant protease with potential to substitute for some functions of the proteasome. Science 283: 978-981.
42. Ostrowska, H., C. Wojcik, S. Omura, and K. Worowski. 1997. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme. Biochem.-Biophys. Res. Commun. 234: 729-732.
43. Frisan, T., V. Levitsky, A. Polack, and M. G. Masucci. 1998. Phenotype-dependent differences in proteasome subunit composition and cleavage specificity in B cell lines. J. Immunol. 160: 3281-329.
44. Cardozo, C., and R. A. Kohanski. 1998. Altered properties of the branched chain amino acid-preferring activity contribute to increased cleavages after branched chain residues by the "immunoproteasome." J. Biol. Chem. 273:16764-16770.
45. Ackerman, A. L., C. Kyritsis, R. Tampe, and P. Cresswell. 2003. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc. Natl. Acad. Sci. USA 100: 12889-12894.
46. + T cells. Nat. Immunol. 6: 593-599.
47. k epitope and evaluation of the role of direct and indirect antigen presentation in HY responses. J. Immunol. 175:7209-7217.
48. Rice, J., S. Buchan, H. Dewchand, E. Simpson, and F. K. Stevenson. 2004. DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire. J. Immunol. 173: 4492-4499.
49. Bassiri, H., J. F. Markmann, N. M. Desai, J. I. Kim, H. S. Teh, and C. F. Barker. 1993. Allograft rejection by T cell receptor transgenic mice. J. Surg. Res. 54: 437-444.
50. + T cell-mediated autoimmunity. J. Exp. Med. 195: 983-990.